Xu Richard Huan, Rencz Fanni, Sun Ruiqi, Dong Dong, Zhang Shuyang
Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Department of Health Policy, Corvinus University of Budapest, Budapest, Hungary.
Value Health. 2025 May;28(5):769-780. doi: 10.1016/j.jval.2025.01.006. Epub 2025 Jan 27.
Our objective was to develop and assess the psychometric properties of relevant bolt-on items for the EQ-5D-5L in patients with rare diseases (RDs).
Nineteen new EQ-5D-5L bolt-ons were developed based on literature review, expert input, and qualitative interviews and focus groups with patients, caregivers, and representatives of patient associations. A nationwide, cross-sectional, web-based survey in China included patients or caregivers of patients with 31 RDs in China (n = 9190). In each RDs, participants completed the EQ-5D-5L and 3 of 20 (1 existing and 19 newly developed) bolt-ons. Ceiling, explanatory power, convergent, divergent, and known-group validity were examined.
Among the bolt-ons, itching had the lowest ceiling (6.5%), whereas social relationships had the highest (42.2%). The absolute reduction in the ceiling of the EQ-5D-5L with the addition of any bolt-ons was limited, ranging from 0 (respiratory problems) to 8.3% points (isolation). Dignity and vitality resulted in the largest increase in explained variance in EQ VAS. The isolation, fertility, and visual acuity bolt-ons showed good divergent validity from the EQ-5D-5L items. There was strong convergent validity between SF-12 and conceptually related bolt-ons (eg, physical health composite and muscle problems bolt-on). Various bolt-ons improved the known-groups validity in specific patient groups, eg, Huntington's disease (oral expressions), scleroderma (dexterity), myasthenia gravis (muscle problems), neuromyelitis optica and multiple sclerosis (fatigue), Marfan syndrome (self-image), and Pompe disease (safety).
The EQ-5D-5L shows sufficient validity in most RDs, but incorporating relevant, specific bolt-ons could enhance its ability to more comprehensively assess health-related quality of life in these patients.
我们的目标是开发并评估针对罕见病(RD)患者的EQ-5D-5L相关附加项目的心理测量特性。
基于文献综述、专家意见以及对患者、护理人员和患者协会代表进行的定性访谈和焦点小组讨论,开发了19个新的EQ-5D-5L附加项目。在中国开展的一项全国性横断面网络调查纳入了中国31种罕见病患者或其护理人员(n = 9190)。在每种罕见病中,参与者完成了EQ-5D-5L以及20个附加项目中的3个(1个现有项目和19个新开发项目)。检验了天花板效应、解释力、收敛效度、区分效度和已知群体效度。
在附加项目中,瘙痒的天花板效应最低(6.5%),而社会关系的天花板效应最高(42.2%)。添加任何附加项目后,EQ-5D-5L天花板效应的绝对降低幅度有限,范围从0(呼吸问题)到8.3个百分点(隔离)。尊严和活力项目使EQ VAS解释变异的增加幅度最大。隔离、生育能力和视力附加项目与EQ-5D-5L项目显示出良好的区分效度。SF-12与概念相关的附加项目(如身体健康综合评分和肌肉问题附加项目)之间存在很强的收敛效度。各种附加项目改善了特定患者群体的已知群体效度,例如亨廷顿舞蹈症(口语表达)、硬皮病(灵巧性)、重症肌无力(肌肉问题)、视神经脊髓炎和多发性硬化症(疲劳)、马凡综合征(自我形象)以及庞贝病(安全性)。
EQ-5D-5L在大多数罕见病中显示出足够的效度,但纳入相关的特定附加项目可以增强其更全面评估这些患者健康相关生活质量的能力。